Patents by Inventor Mohammad Basabrain

Mohammad Basabrain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia
    Patent number: 12285418
    Abstract: Three compounds having a common molecular template of 2-(5-(N-acylamino)pyridin-2-yl)-N-benzylacetamide (Compounds I, II and I) are identified as potential anticancer therapeutic agents, and for the treatment of Acute Myeloid Leukemia (AML) in particular. Compound I was specifically designed to target AML cells, inhibit growth, and induce cell death. Compound I demonstrated a dose-dependent effect on AML cell lines HL-60, Mv4-11, KG-1a, and K562.
    Type: Grant
    Filed: August 29, 2024
    Date of Patent: April 29, 2025
    Assignees: University of Jeddah, King Abdulaziz University
    Inventors: Roaa M. Alreemi, Hind A. Alkhatabi, Abdelsattar M. Omar, Mohammed A. Baradwan, Yosra A. Muhammad, Peter Natesan Pushparaj, Mohammad Basabrain, Moustafa E. El-Araby